Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

ATM S927-p , S2339-p , S2636-p , S3377-p , S3695-p , S3797-p
ATR S2391-p
Regulatory protein:
PRP4 S1907-p
Treatment:
angiotensin_2 S3919-p , T3924-p
AZD1152 S2362-p , T2366-p , S2370-p , S2936-p
BI2536 S2365-p , T2366-p
EGF S1084-p , S3919-p , T3924-p
hydroxyurea S927-p , S2339-p , S2636-p , S3377-p , S3695-p , S3797-p
ionizing_radiation S927-p , S2339-p , S2636-p , S3377-p , S3695-p , S3797-p
ischemia S1084-p , S1368-p , S1370-p , S1395-p , S2266-p , S2593-p , S3116-p , S3117-p , S3158-p , S3662-p , S3757-p , S3919-p , T3924-p
metastatic potential S649-p , S1907-p
MG132 K1608-ub
MLN8054 S2365-p , S2594-p , S2600-p , S2936-p , S3127-p , S3752-p , S3753-p , S3757-p , S3760-p
MS275 K1840-ac
nocodazole S1084-p , S1368-p , S2362-p , S2365-p , S3127-p , S3757-p , S3760-p , S3906-p , S3919-p
SB202190 S1084-p
selumetinib S1903-p , S1907-p , S3752-p , S3919-p
U0126 T3924-p
UV S2377-p , S2391-p , S3377-p
vemurafenib S1903-p , S1907-p , S3752-p , S3919-p
ZM447439 S2362-p , T2366-p , S2370-p , S2936-p